GILD270115P00120000 Option on Gilead Sciences
| GILD Stock | USD 92.34 1.75 1.93% |
Gilead Sciences' latest option contracts expiring on 2024-12-13 are carrying combined implied volatility of 0.14 with a put-to-call open interest ratio of 0.0 over 54 outstanding agreements suggesting investors are buying way more calls than puts on contracts expiring on 2024-12-13. The total put volume is at 213, with calls trading at the volume of 213. This yields a 0.11 put-to-call volume ratio.
In The Money vs. Out of Money Option Contracts on Gilead Sciences
Analyzing Gilead Sciences' in-the-money options over time can help investors to take a profitable long position in Gilead Sciences regardless of its overall volatility. This is especially true when Gilead Sciences' options are deep in the money. These options can be identified using deltas that are over 0.75. Deep in-the-money Gilead Sciences' options could be used as guardians of the underlying stock as they move almost dollar for dollar with Gilead Sciences' stock while costing only a fraction of its price.
Gilead Sciences' stock options are financial instruments that give investors the right to buy or sell shares of Gilead Sciences common stock at a specified price for a given time period. Generally speaking, an option to purchase or sell Gilead stock makes it part of the underlying stock when the option's price is tied to the movement of the underlying stock. If Gilead Sciences' stock price goes up or down, the stock options follow.
At present, Gilead Sciences' Common Stock Shares Outstanding is projected to increase significantly based on the last few years of reporting. The current year's Liabilities And Stockholders Equity is expected to grow to about 65.2 B, whereas Capital Stock is forecasted to decline to about 901 K. Gilead Sciences In The Money Call Balance
When Gilead Sciences' strike price is surpassing the current stock price, the option contract against Gilead Sciences stock is said to be in the money. When it comes to buying Gilead Sciences' options that are 'In the Money' or 'Out of the Money', the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
While 'out-of-the-money' option contracts written on Gilead Sciences are typically viewed as the more aggressive, there are potential upsides to purchasing these types of options contracts. For one, the cost to buy an 'Out of the Money' option is lower than the cost to buy an 'In the Money' option. This cost-benefit is due to the fact that at the time of the purchase, 'Out of the Money' contracts have no intrinsic value. So, while the potential for a 100% loss is more significant, the cost and risk to enter the trade are lower.
Gilead Current Options Market Mood
Gilead Sciences' open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Gilead Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.
Put-to-Call Volume
Unfortunately, most Gilead Sciences' options investors are not very successful. Gilead Sciences' option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction.
Rule 16 of the current Gilead contract
Base on the Rule 16, the options market is currently suggesting that Gilead Sciences will have an average daily up or down price movement of about 0.00875% per day over the life of the 2024-12-13 option contract. With Gilead Sciences trading at USD 92.34, that is roughly USD 0.00808. If you think that the market is fully incorporating Gilead Sciences' daily price movement you should consider buying Gilead Sciences options at the current volatility level of 0.14%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Gilead |
Purchasing Gilead Sciences options can give investors a meaningful hedge against losses and, therefore, could be used conservatively to decrease the volatility of your portfolio. However, many options could also amount to little more than gambling, significantly enhancing your overall portfolio risk. One simple example of these aggressive strategies is the sale of "uncovered" Gilead calls. Remember, the seller must deliver Gilead Sciences stock to the call owner when a call is exercised.
Gilead Sciences Option Chain
When Gilead Sciences' strike price is surpassing the current stock price, the option contract against Gilead Sciences stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
2024-12-132024-12-202024-12-272025-01-032025-01-102025-01-172025-01-242025-02-212025-05-162025-06-202025-09-192026-01-162027-01-15
Gilead Sciences' option chain is a display of a range of information that helps investors for ways to trade options on Gilead. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Gilead. It also shows strike prices and maturity days for a Gilead Sciences against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone. | Open Int | Expiration | Current Spread | Last Price | |||
Call | GILD Option Call 13-12-2024 65 | 0 | 2024-12-13 | 0.0 - 0.0 | 24.04 | In |
Call | GILD Option Call 13-12-2024 70 | 0 | 2024-12-13 | 0.0 - 0.0 | 16.8 | In |
Call | GILD Option Call 13-12-2024 75 | 0 | 2024-12-13 | 0.0 - 0.0 | 15.95 | In |
Call | GILD Option Call 13-12-2024 78 | 0 | 2024-12-13 | 0.0 - 0.0 | 14.48 | In |
Call | GILD Option Call 13-12-2024 79 | 0 | 2024-12-13 | 0.0 - 0.0 | 12.87 | In |
Call | GILD Option Call 13-12-2024 81 | 0 | 2024-12-13 | 0.0 - 0.0 | 8.64 | In |
Call | GILD Option Call 13-12-2024 84 | 0 | 2024-12-13 | 0.0 - 0.0 | 9.63 | In |
Call | GILD Option Call 13-12-2024 85 | 0 | 2024-12-13 | 0.0 - 0.0 | 6.0 | In |
Call | GILD Option Call 13-12-2024 86 | 0 | 2024-12-13 | 0.0 - 0.0 | 3.98 | In |
Call | GILD Option Call 13-12-2024 87 | 0 | 2024-12-13 | 0.0 - 0.0 | 5.84 | In |
Call | GILD Option Call 13-12-2024 88 | 0 | 2024-12-13 | 0.0 - 0.0 | 3.03 | In |
Call | GILD Option Call 13-12-2024 89 | 0 | 2024-12-13 | 0.0 - 0.0 | 3.91 | In |
Call | GILD Option Call 13-12-2024 90 | 0 | 2024-12-13 | 0.0 - 0.0 | 2.53 | In |
Call | GILD Option Call 13-12-2024 91 | 0 | 2024-12-13 | 0.0 - 0.0 | 2.16 | In |
Call | GILD Option Call 13-12-2024 92 | 0 | 2024-12-13 | 0.0 - 0.0 | 1.61 | In |
Call | GILD Option Call 13-12-2024 93 | 0 | 2024-12-13 | 0.0 - 0.0 | 0.69 | |
Call | GILD Option Call 13-12-2024 94 | 0 | 2024-12-13 | 0.0 - 0.0 | 0.37 | |
Call | GILD Option Call 13-12-2024 95 | 0 | 2024-12-13 | 0.0 - 0.0 | 0.23 | |
Call | GILD Option Call 13-12-2024 96 | 0 | 2024-12-13 | 0.0 - 0.0 | 0.15 | |
Call | GILD Option Call 13-12-2024 97 | 0 | 2024-12-13 | 0.0 - 0.0 | 0.1 | |
Call | GILD Option Call 13-12-2024 98 | 0 | 2024-12-13 | 0.0 - 0.0 | 0.05 | |
Call | GILD Option Call 13-12-2024 99 | 0 | 2024-12-13 | 0.0 - 0.0 | 0.01 | |
Call | GILD Option Call 13-12-2024 100 | 0 | 2024-12-13 | 0.0 - 0.0 | 0.01 | |
Call | GILD Option Call 13-12-2024 101 | 0 | 2024-12-13 | 0.0 - 0.0 | 0.11 | |
Call | GILD Option Call 13-12-2024 102 | 0 | 2024-12-13 | 0.0 - 0.0 | 0.07 | |
Call | GILD Option Call 13-12-2024 103 | 0 | 2024-12-13 | 0.0 - 0.0 | 0.04 | |
Call | GILD Option Call 13-12-2024 104 | 0 | 2024-12-13 | 0.0 - 0.0 | 0.02 | |
Call | GILD Option Call 13-12-2024 105 | 0 | 2024-12-13 | 0.0 - 0.0 | 0.01 | |
Call | GILD Option Call 13-12-2024 110 | 0 | 2024-12-13 | 0.0 - 0.0 | 0.06 | |
Put | GILD Option Put 13-12-2024 60 | 0 | 2024-12-13 | 0.0 - 0.0 | 0.01 | |
Put | GILD Option Put 13-12-2024 65 | 0 | 2024-12-13 | 0.0 - 0.0 | 0.02 | |
Put | GILD Option Put 13-12-2024 70 | 0 | 2024-12-13 | 0.0 - 0.0 | 0.05 | |
Put | GILD Option Put 13-12-2024 78 | 0 | 2024-12-13 | 0.0 - 0.0 | 0.07 | |
Put | GILD Option Put 13-12-2024 79 | 0 | 2024-12-13 | 0.0 - 0.0 | 0.2 | |
Put | GILD Option Put 13-12-2024 81 | 0 | 2024-12-13 | 0.0 - 0.0 | 0.35 | |
Put | GILD Option Put 13-12-2024 82 | 0 | 2024-12-13 | 0.0 - 0.0 | 0.04 | |
Put | GILD Option Put 13-12-2024 83 | 0 | 2024-12-13 | 0.0 - 0.0 | 0.02 | |
Put | GILD Option Put 13-12-2024 84 | 0 | 2024-12-13 | 0.0 - 0.0 | 0.07 | |
Put | GILD Option Put 13-12-2024 85 | 0 | 2024-12-13 | 0.0 - 0.0 | 0.04 | |
Put | GILD Option Put 13-12-2024 86 | 0 | 2024-12-13 | 0.0 - 0.0 | 0.11 | |
Put | GILD Option Put 13-12-2024 87 | 0 | 2024-12-13 | 0.0 - 0.0 | 0.08 | |
Put | GILD Option Put 13-12-2024 88 | 0 | 2024-12-13 | 0.0 - 0.0 | 0.11 | |
Put | GILD Option Put 13-12-2024 89 | 0 | 2024-12-13 | 0.0 - 0.0 | 0.42 | |
Put | GILD Option Put 13-12-2024 90 | 0 | 2024-12-13 | 0.0 - 0.0 | 0.53 | |
Put | GILD Option Put 13-12-2024 91 | 0 | 2024-12-13 | 0.0 - 0.0 | 1.01 | |
Put | GILD Option Put 13-12-2024 92 | 0 | 2024-12-13 | 0.0 - 0.0 | 0.98 | |
Put | GILD Option Put 13-12-2024 93 | 0 | 2024-12-13 | 0.0 - 0.0 | 3.3 | In |
Put | GILD Option Put 13-12-2024 94 | 0 | 2024-12-13 | 0.0 - 0.0 | 2.67 | In |
Put | GILD Option Put 13-12-2024 95 | 0 | 2024-12-13 | 0.0 - 0.0 | 2.62 | In |
Put | GILD Option Put 13-12-2024 96 | 0 | 2024-12-13 | 0.0 - 0.0 | 3.35 | In |
Put | GILD Option Put 13-12-2024 98 | 0 | 2024-12-13 | 0.0 - 0.0 | 5.2 | In |
Put | GILD Option Put 13-12-2024 99 | 0 | 2024-12-13 | 0.0 - 0.0 | 3.04 | In |
Put | GILD Option Put 13-12-2024 103 | 0 | 2024-12-13 | 0.0 - 0.0 | 10.0 | In |
Put | GILD Option Put 13-12-2024 107 | 0 | 2024-12-13 | 0.0 - 0.0 | 15.8 | In |
Gilead Sciences Selling And Marketing Expenses Over Time
Selling And Marketing Expenses |
| Timeline |
Gilead Total Stockholder Equity
Total Stockholder Equity |
|
Gilead Sciences Corporate Management
| Johanna Mercier | Chief Commercial Officer | Profile | |
| Michael Quigley | VP Biology | Profile | |
| Linda Higgins | Innovation Research | Profile | |
| Deborah Telman | General Affairs | Profile |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Gilead Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. For information on how to trade Gilead Stock refer to our How to Trade Gilead Stock guide.You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Gilead Sciences. If investors know Gilead will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Gilead Sciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.42) | Dividend Share 3.06 | Earnings Share 0.09 | Revenue Per Share 22.703 | Quarterly Revenue Growth 0.07 |
The market value of Gilead Sciences is measured differently than its book value, which is the value of Gilead that is recorded on the company's balance sheet. Investors also form their own opinion of Gilead Sciences' value that differs from its market value or its book value, called intrinsic value, which is Gilead Sciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Gilead Sciences' market value can be influenced by many factors that don't directly affect Gilead Sciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Gilead Sciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Gilead Sciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Gilead Sciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.